Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q2178381> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- Q2178381 subject Q8255962.
- Q2178381 subject Q8421769.
- Q2178381 subject Q8501360.
- Q2178381 abstract "Darbepoetin alfa (rINN) /dɑːrbəˈpɔɪtᵻn/ is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.The drug was approved in September 2001 by the Food and Drug Administration for treatment of anemia in patients with chronic renal failure by intravenous or subcutaneous injection. In June 2001, it had been approved by the European Medicines Agency for this indication as well as the treatment of anemia in cancer patients undergoing chemotherapy.Dr. Reddy's Laboratories launched darbepoetin alfa in India under the brand name ‘Cresp’ in August 2010. This is the world’s first generic darbepoetin alfa. Cresp has been approved in India.Darbepoetin is produced by recombinant DNA technology in modified Chinese hamster ovary cells. It differs from endogenous erythropoietin (EPO) by containing two more N-linked oligosaccharide chains. It is an erythropoiesis-stimulating 165-amino acid protein.".
- Q2178381 atcPrefix "B03".
- Q2178381 atcSuffix "XA02".
- Q2178381 casNumber "11096-26-7".
- Q2178381 drugbank "DB00012".
- Q2178381 fdaUniiCode "15UQ94PT4P".
- Q2178381 wikiPageWikiLink Q12152.
- Q2178381 wikiPageWikiLink Q1216998.
- Q2178381 wikiPageWikiLink Q12202.
- Q2178381 wikiPageWikiLink Q130146.
- Q2178381 wikiPageWikiLink Q1363798.
- Q2178381 wikiPageWikiLink Q14852026.
- Q2178381 wikiPageWikiLink Q14904899.
- Q2178381 wikiPageWikiLink Q152234.
- Q2178381 wikiPageWikiLink Q181754.
- Q2178381 wikiPageWikiLink Q183605.
- Q2178381 wikiPageWikiLink Q18544844.
- Q2178381 wikiPageWikiLink Q202837.
- Q2178381 wikiPageWikiLink Q204711.
- Q2178381 wikiPageWikiLink Q235747.
- Q2178381 wikiPageWikiLink Q261327.
- Q2178381 wikiPageWikiLink Q261351.
- Q2178381 wikiPageWikiLink Q2751330.
- Q2178381 wikiPageWikiLink Q275419.
- Q2178381 wikiPageWikiLink Q2843019.
- Q2178381 wikiPageWikiLink Q285697.
- Q2178381 wikiPageWikiLink Q37187.
- Q2178381 wikiPageWikiLink Q4.
- Q2178381 wikiPageWikiLink Q41861.
- Q2178381 wikiPageWikiLink Q466892.
- Q2178381 wikiPageWikiLink Q470517.
- Q2178381 wikiPageWikiLink Q514525.
- Q2178381 wikiPageWikiLink Q5204237.
- Q2178381 wikiPageWikiLink Q5383794.
- Q2178381 wikiPageWikiLink Q5445.
- Q2178381 wikiPageWikiLink Q56646.
- Q2178381 wikiPageWikiLink Q6279182.
- Q2178381 wikiPageWikiLink Q702885.
- Q2178381 wikiPageWikiLink Q736715.
- Q2178381 wikiPageWikiLink Q8054.
- Q2178381 wikiPageWikiLink Q8066.
- Q2178381 wikiPageWikiLink Q824258.
- Q2178381 wikiPageWikiLink Q8255962.
- Q2178381 wikiPageWikiLink Q837174.
- Q2178381 wikiPageWikiLink Q8421769.
- Q2178381 wikiPageWikiLink Q8501360.
- Q2178381 wikiPageWikiLink Q879952.
- Q2178381 wikiPageWikiLink Q908961.
- Q2178381 wikiPageWikiLink Q9668.
- Q2178381 wikiPageWikiLink Q974135.
- Q2178381 atcPrefix "B03".
- Q2178381 atcSuffix "XA02".
- Q2178381 casNumber "11096".
- Q2178381 drugbank "DB00012".
- Q2178381 unii "15".
- Q2178381 type ChemicalSubstance.
- Q2178381 type Drug.
- Q2178381 type ChemicalObject.
- Q2178381 type Thing.
- Q2178381 type Q8386.
- Q2178381 comment "Darbepoetin alfa (rINN) /dɑːrbəˈpɔɪtᵻn/ is a synthetic form of erythropoietin. It stimulates erythropoiesis (increases red blood cell levels) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy. Darbepoetin is marketed by Amgen under the trade name Aranesp.The drug was approved in September 2001 by the Food and Drug Administration for treatment of anemia in patients with chronic renal failure by intravenous or subcutaneous injection.".
- Q2178381 label "Darbepoetin alfa".